NCT04021342

The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Physiological and Cognitive Function

The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Cardiometabolic Risk Factors, Exercise Capacity and Cognitive Function

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Northumbria University · Academic / Other
• Sex: All
• Age: 40 Years – 60 Years
• Healthy volunteers: Accepted

Summary

A randomized, double blind, counterbalanced, placebo controlled independent groups design to determine the effects of 3 month supplementation with tart cherry concentrate on indices of cardiometabolic health, exercise capacity and cognitive function. Following screening and recruitment, participants are familiarised with the testing equipment and procedures after which they will be randomly assigned to receive either Montmorency tart cherry concentrate (MC) or an isocaloric placebo (PLA), stratified by gender. The study is comprised of two experimental visits and outcome variables are assessed at baseline (before supplementation) and at 3 months (follow up; after supplementation).

Conditions

• Cardiometabolic Risk Factors
• Cognitive Function
• Exercise Capacity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Montmorency tart cherry concentrate	Based on previous analysis done by our laboratory each 60 ml of Montmorency tart cherry concentrate contains approximately 73.5 mg of anthocyanins (cyanidin-3-glucoside equivalents) and 178.8 mg of total phenolics (mean gallic acid equivalents)
DIETARY_SUPPLEMENT	Placebo	Placebo beverage matched for calorie content and visual properties of the cherry concentrate

Timeline

• Start date: 2018-10-12
• Primary completion: 2019-11-29
• Completion: 2020-02-29
• First posted: 2019-07-16
• Last updated: 2021-04-08

Locations

1 site across 1 country: United Kingdom